Last reviewed · How we verify

NCT03691155

The Feasibility of Following the Crohn's Diet

Completed NA Last updated 26 February 2019
What this trial tests

NA trial testing The Crohn's Diet in Crohn Disease in 20 participants. Completed in 18 December 2018.

Timeline
8 July 2018
Primary endpoint
18 December 2018
18 December 2018

Quick facts

Lead sponsorKing's College London
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingsingle
Primary purposeother
Enrollment20
Start date8 July 2018
Primary completion18 December 2018
Estimated completion18 December 2018
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

King's College London

Who can join

18 and older, any sex, with Crohn Disease or Inflammatory Bowel Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A research team from King's College London are investigating how diet can be used as a treatment for Crohn's disease. The investigators have designed a new diet and eventually wish to test whether the diet can be used to manage Crohn's disease and reduce gut inflammation. Before doing this, the investigators need to find out how practical it is for people to follow the diet for 14 days by conducting this 'feasibility' study. A feasibility study is a small study that aims to highlight any issues before informing the design of a larger research trial. The diet the investigators have designed is called the Crohn's Diet. The evidence for this diet is based on recent research which suggests that certain food ingredients may be involved in triggering gut inflammation. The study's primary aim is to assess the practicalities of following the Crohn's Diet. It will also assess compliance to the Crohn's Diet and if following it changes the nutritional balance from the normal diet.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Emulsifiers Impact Colonic Length in Mice and Emulsifier Restriction is Feasible in People with Crohn's Disease.
    Sandall AM, Cox SR, Lindsay JO, Gewirtz AT, et al · · 2020 · cited 46× · PMID 32942699 · DOI 10.3390/nu12092827

Verify or expand the search:

Other recruiting trials for Crohn Disease

Currently open trials in the same condition.

Other King's College London trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03691155.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing